United States · Funded startup

Who invested in ARIZ Precision Medicine

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$1.0Mraised across 1 round since 2022, from 1 source

Latest round
Round, $1.0MMar 2022
Investors
1
See who backed them

The rounds

  1. Mar 2022
    Round$1.0M

    Source recorded

Founders and team

From ARIZ Precision Medicine's own website and the SEC filings it signed: 6 on the team.

  • Glenn KazoChief Business Officer
  • Dr. Manish BhandariBoard Member
  • Brad NilesExecutive Officer, Directori
  • Kevin NagleBoard Member
  • Lokesh SikariaBoard Member
  • Lonnie BookbinderExecutive Officer, Directori

On the board, as filediSabya Das

Everyone who backed them

Moneta VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about ARIZ Precision Medicine

Who invested in ARIZ Precision Medicine?

ARIZ Precision Medicine's investors include Moneta Ventures.

How much has ARIZ Precision Medicine raised?

ARIZ Precision Medicine has raised $1.0M across 1 round since 2022.

When did ARIZ Precision Medicine last raise?

ARIZ Precision Medicine's most recent round was an Undisclosed round of $1.0M in Mar 2022.

What was ARIZ Precision Medicine's biggest round?

Its most recent round, $1.0M in Mar 2022, is also its largest on record.

Who backed ARIZ Precision Medicine first?

ARIZ Precision Medicine's first round on record, in Mar 2022, was backed by Moneta Ventures.

What stage is ARIZ Precision Medicine at?

ARIZ Precision Medicine's latest named round is an Undisclosed round, in Mar 2022.

Where is ARIZ Precision Medicine based?

ARIZ Precision Medicine is based in the United States.

Companies like ARIZ Precision Medicine

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.